← Eichor
Study identifier: NCT07491601 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

Condition: Postoperative Hypoparathyroidism · Postsurgical Hypoparathyroidism · Hypoparathyroidism Post-surgical  ·  Sponsor: Nicolas Schlegel

PhaseNA
Planned participants336
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.

This description comes directly from the study's public registry record.

Talk to the study team

Nicolas Schlegel, Prof. Dr. (MD)  ·  +49 931 201 38217  ·  SCHLEGEL_N@ukw.de

Nicole Kirschbauer, Study Nurse  ·  +49 931 201 31173  ·  kirschbauer_n@ukw.de

Always discuss trial participation with your own doctor first.

Locations (1)

Dept. Surgery I; University Hospital WuerzburgWürzburg, Bavaria, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07491601